Thursday, December 25, 2025
HomeIndustriesHealthcare

Healthcare

U.S. Neurologists Cautiously Optimistic Following Accelerated Approval and Launch of Eisai/Biogen’s Leqembi for Early Alzheimer’s Disease, According to Spherix Global Insights

With the accelerated approval on January 6, 2023 for early Alzheimer's disease, Eisai/Biogen's Leqembi became only the second approved disease-modifying therapy (DMT) for early Alzheimer's...

Nordic Consulting Expands Managed Services Offerings

Nordic Consulting, a global health and technology consulting company, announced the expansion of its offerings to include a full suite of managed services. The...

National Kidney Foundation Appoints Vizient, Inc. Executive to National Board of Directors

The National Kidney Foundation (NKF) is thrilled to announce the appointment of Monica Davy, Senior Vice President and Chief Culture, Diversity, and Impact Officer at Vizient,...

Johnson & Johnson to pay $8.9 billion to settle lawsuits over ‘cancer-causing’ talc

The US-based pharmaceutical and baby products company said that the proposed settlement, which still needs the approval of a bankruptcy court, "will equitably and...

Providence and GRAIL Expand Partnership to Increase Access to Galleri® Multi-Cancer Early Detection Screening

Providence, a not-for-profit health system serving the Western U.S, and GRAIL, LLC, a healthcare company with a mission to detect cancer early when it...
0FansLike
0FollowersFollow
spot_img

Hot Topics